AzTrials
AzTrials

EsophagectomyNCT05950438

Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

An observational study of Esophagectomy, run by Northwestern University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure. Clinical (or health) outcomes measure the effect of the procedure on your overall health status. During this procedure, the surgeon will remove all or part of your esophagus. Read more about this study

Who is it for?
Ages 18 to 89 years
Conditions the study is for
Esophagectomy
What is being tested?
Esophagectomy
Type of treatment
Surgery or procedure
How many people
120 participants
Where
1 siteUnited States
Study dates
11 Jul 2023to 25 May 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participants will be identified in the Thoracic Surgery clinic or in the inpatient setting based on the surgeon's expertise who need to undergo an elective esophagectomy procedure.

Who may be able to join

  • Adult patients (18 years or older)
  • Patients undergoing elective esophagectomy for any indication
  • Patients who have already had an elective esophagectomy for any indication
  • Patients with consent providing capacity

Who cannot join

  • Patients undergoing emergent esophagectomy
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sara Krezalek, BSN contact

312-926-7577

sara.krezalek@nm.org

United States1 site, 1 recruiting
  • Northwestern University

    Chicago, Illinois, 60611

    Ankit Bharat, MD, 3129267628, ankit.bharat@northwestern.edu

    Sara Krezalek, BSN, 3129267577, sara.krezalek@nm.org

    Recruiting

Other trials in United States

About this study

Official title: A Prospective Clinical Registry Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure. Clinical (or health) outcomes measure the effect of the procedure on your overall health status. During this procedure, the surgeon will remove all or part of your esophagus. We want to identify patients who will have this procedure. We will look at data elements before, during, and after your procedure to understand the impact of this surgery on your post-operative clinical outcomes.

Read the detailed description

Esophagectomy is a complex surgical procedure performed to treat various esophageal disorders. The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract. Different surgical approaches and techniques have been developed, including open (transthoracic or transhiatal), minimally invasive (video-assisted thoracoscopic surgery or robotic-assisted), and hybrid approaches. These techniques may yield different clinical outcomes, and there is still ongoing debate regarding the optimal approach. Nevertheless, minimally invasive approaches, including robotic esophagectomy, are generally preferred given the lower morbidity. This prospective clinical registry aims to investigate outcomes of elective robotic transhiatal esophagectomy, the preferred approach at Northwestern Memorial Hospital, for adult patients undergoing this procedure. By collecting clinical and demographic data prospectively, we hope to identify factors that contribute to improved outcomes and guide future surgical practice.

Conditions
Esophagectomy
Being tested
Esophagectomy
Keywords
Robotic Transhiatal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EsophagectomyProcedure or surgery

    Esophagectomy is a complex surgical procedure performed to treat various esophageal disorders. The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants with Anastomotic Leak

    Postoperative Complication

    Measured: During first 3 months postop

  2. Number of Participants with Esophageal Stricture

    Postoperative Complication

    Measured: During first 3 months postop

  3. Number of Participants with Pneumonia

    Postoperative Complication

    Measured: During first 3 months postop

  4. Number of Participants Requiring Ventilation >48 Hours

    Postoperative Complication

    Measured: During first 3 months postop

  5. Number of Participants with Empyema

    Postoperative Complication

    Measured: During first 3 months postop

  6. Number of Participants with Pulmonary Embolism

    Postoperative Complication

    Measured: During first 3 months postop

  7. Number of Participants with Deep Venous Thrombosis

    Postoperative Complication

    Measured: During first 3 months postop

  8. Number of Participants with Gastric Outlet Obstruction

    Postoperative Complication

    Measured: During first 3 months postop

  9. Number of Participants with Stroke

    Postoperative Complication

    Measured: During first 3 months postop

  10. Number of Participants with Atrial Fibrillation

    Postoperative Complication

    Measured: During first 3 months postop

  11. Number of Participants with Vocal Cord Paralysis

    Postoperative Complication

    Measured: During first 3 months postop

  12. Number of Participants with Myocardial Infarction

    Postoperative Complication

    Measured: During first 3 months postop

  13. Number of Participants with Chylothorax

    Postoperative Complication

    Measured: During first 3 months postop

  14. Number of Participants with Acute Renal Injury

    Postoperative Complication

    Measured: During first 3 months postop

  15. Number of Participants with Wound Infections

    Postoperative Complication

    Measured: During first 3 months postop

  16. Rates of Re-operation

    Postoperative Complication

    Measured: During first 3 months postop

  17. Rates of Re-Admission

    Postoperative Complication

    Measured: During first 3 months postop

  18. Number of Participants with Intensive Care Unit (ICU) Stay

    Postoperative Complication

    Measured: During first 3 months postop

  19. Rates of Length of Hospital Stay

    Postoperative Complication

    Measured: Postoperative

  20. Rates of 30-day Survival

    Postoperative Complication

    Measured: Postoperative

  21. Rates of 90-day Survival Rates

    Postoperative Complication

    Measured: Postoperative

Secondary outcomes (5)
  1. Operative Time of Surgery

    Length of Surgery

    Measured: Intraoperative

  2. Rates of Blood Loss

    Did the Participant Lose Any Blood During the Surgery

    Measured: Intraoperative

  3. Number of Participants with Conversion Rates to Open Esophagectomy

    Measured: Intraoperative

  4. Number of Participants with Lymph nodes in the Final Specimen

    Pathological Variables

    Measured: Intraoperative

  5. Number of Participants with Proximal and Distal Margins

    Pathological Variables

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2023
  2. Study start11 Jul 2023
  3. Primary completion25 May 2028 (estimated)
  4. Study completion25 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05950438
Sponsor's protocol ID
STU00219267
Status last verified
May 2026
First submitted
11 Jul 2023
Last updated
26 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Esophagectomy, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ankit Bharat, MD (312-926-7628, ankit.bharat@northwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants with Anastomotic Leak (time frame: During first 3 months postop). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in